One of three listed pharmaceutical companies spent over 40% of sales into sales management expenses

One of three listed pharmaceutical companies were aggregated to spend 40% of their sales on sales management expenses. In order to raise profits, pharmaceutical companies have been working on reducing the fees, but it seems they have not been able to bear fruits from the efforts.   

According to the Yakup Shinmoon’s analysis result of the 2015 audit reports of KOSPI and KOSDAQ listed pharmaceu...